FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Makary Details DTC Enforcement Crackdown on Podcast

FDA commissioner Marty Makary addresses during a podcast the agencys significant shift in enforcement policy directed at pharmaceutical advertis...

latest-news-card-1
Human Drugs

Report on Ways to Cut Reliance on Foreign Drugs

The Senate Special Committee on Aging releases a report with six recommendations for reducing the use of foreign-made drugs for seniors.

latest-news-card-1
Human Drugs

FDA Still Finding Issues at Nephron Pharmaceuticals

A South Carolina newspaper reports that the latest FDA inspection at Nephron Pharmaceuticals found the company still has significant quality issues.

Biologics

Moderna Quits CMV Vaccine After Phase 3 Failure

Moderna stops the development of its congenital cytomegalovirus vaccine after it failed to meet the primary endpoint in a large Phase 3 trial.

latest-news-card-1
Biologics

sBLA for PadcevKeytruda Combo in Bladder Cancer

FDA accepts for priority review an Astellas supplemental BLA for Padcev (enfortumab vedotin-ejfv) in combination with Mercks Keytruda (pembrolizumab) ...

latest-news-card-1
Human Drugs

CGMP Issues Seen in Foshan Records Review

FDA warns Chinas Foshan Yiying Hygiene Products Co. about CGMP issues in its production of over-the-counter drugs.

latest-news-card-1
Human Drugs

Alector Scraps Dementia Drug After Missing Key Endpoint

Alector discontinues development of latozinemab for treating a rare genetic form of frontotemporal dementia after a Phase 3 trial missed its primary e...

latest-news-card-1
Human Drugs

3rd Patient-Focused Drug Development Guidance

FDA publishes the third in a series of guidances on aspects of collecting patient experience data to be used in medical product development and regula...

latest-news-card-1
Medical Devices

QS Violations in Dongguan Rainbow Tech Inspection

FDA warns Chinas Dongguan Rainbow Tech Electronic & Plastics Co. about Quality System Regulation violations in its manufacturing of manual emergency v...

latest-news-card-1
Human Drugs

Fast Track for Myosin Glioblastoma Drug

FDA awards a fast track designation to Myosin Therapeutics and its investigational drug MT-125 for treating brain cancer.